Virtu Financial LLC

Position in IBIO — iBio, Inc.

CIK 1533964 New York, NY

Position in IBIO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$20,561

-$14,216 QoQ

Shares Held

10,822

-74.2% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Virtu Financial LLC holds $37,834,089 across 147 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	58,459	$4,130,128
2	APGE	Apogee Therapeutics, Inc.	29,790	$3,954,026
3	ABVX	Abivax S.A.	19,155	$2,552,595
4	AXSM	Axsome Therapeutics, Inc.	9,220	$2,256,779
5	KYMR	Kymera Therapeutics, Inc.	12,556	$1,439,796
6	PTGX	Protagonist Therapeutics, Inc	8,163	$1,000,620
7	TGTX	Tg Therapeutics, Inc.	17,524	$962,768
8	IOVA	Iovance Biotherapeutics, Inc.	221,500	$921,440

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$20,561	10,822	-74.2%	Shares	Defined	2026-05-14
2025-09-30	$34,777	41,900	+4.3%	Shares	Defined	2025-11-14
2025-06-30	$30,537	40,181	+23.9%	Shares	Defined	2025-08-12
2023-09-30	$9,729	32,432	-29.3%	Shares	Defined	2023-11-15
2023-03-31	$95,411	45,871	-2.2%	Shares	Defined	2023-05-01
2022-12-31	$20,637	46,904	-61.5%	Shares	Defined	2023-02-15
2022-06-30	$31,675	121,828	+182.4%	Shares	Defined	2022-08-09
2022-03-31	$18,548	43,136	-76.0%	Shares	Defined	2022-05-17
2021-12-31	$98,857	179,740	-0.7%	Shares	Defined	2022-02-17
2021-09-30	$191,959	181,094	+93.2%	Shares	Defined	2021-11-12
2021-03-31	$144,379	93,753	+69.5%	Shares	Defined	2021-05-19
2020-12-31	$58,068	55,303	-80.7%	Shares	Defined	2021-02-24
2020-09-30	$580,577	285,999	+607.3%	Shares	Defined	2020-12-11
2020-06-30	$89,772	40,438	—	Shares	Defined	2020-08-07
No filing history on record for this holder in this stock.